Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Non-rural point source blastomycosis outbreak near a yard waste collection site.

Pfister JR, Archer JR, Hersil S, Boers T, Reed KD, Meece JK, Anderson JL, Burgess JW, Sullivan TD, Klein BS, Wheat LJ, Davis JP.

Clin Med Res. 2011 Jun;9(2):57-65. doi: 10.3121/cmr.2010.958. Epub 2010 Oct 25.

2.

Decision analysis: point-of-care Chlamydia testing vs. laboratory-based methods.

Swain GR, McDonald RA, Pfister JR, Gradus MS, Sedmak GV, Singh A.

Clin Med Res. 2004 Feb;2(1):29-35.

3.

Targeted laboratory screening for sexually transmitted and bloodborne infections in Wisconsin.

Pfister JR, Golubjatnikov R, Arcari CM, Davis JP.

WMJ. 2003;102(6):35-9.

4.

Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.

Roberts CM, Pfister JR, Spear SJ.

Sex Transm Dis. 2003 Oct;30(10):797-800.

PMID:
14520181
5.

N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.

Elworthy TR, Ford AP, Bantle GW, Morgans DJ Jr, Ozer RS, Palmer WS, Repke DB, Romero M, Sandoval L, Sjogren EB, Talamás FX, Vazquez A, Wu H, Arredondo NF, Blue DR Jr, DeSousa A, Gross LM, Kava MS, Lesnick JD, Vimont RL, Williams TJ, Zhu QM, Pfister JR, Clarke DE.

J Med Chem. 1997 Aug 15;40(17):2674-87.

PMID:
9276013
6.

Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine.

Pfister JR, Belardinelli L, Lee G, Lum RT, Milner P, Stanley WC, Linden J, Baker SP, Schreiner G.

J Med Chem. 1997 Jun 6;40(12):1773-8.

PMID:
9191953
7.

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.

Ford AP, Arredondo NF, Blue DR Jr, Bonhaus DW, Jasper J, Kava MS, Lesnick J, Pfister JR, Shieh IA, Vimont RL, Williams TJ, McNeal JE, Stamey TA, Clarke DE.

Mol Pharmacol. 1996 Feb;49(2):209-15.

PMID:
8632751
8.

Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Blue DR Jr, Bonhaus DW, Ford AP, Pfister JR, Sharif NA, Shieh IA, Vimont RL, Williams TJ, Clarke DE.

Br J Pharmacol. 1995 May;115(2):283-94.

9.

RS-33295-198: a novel, potent modulator of P-glycoprotein-mediated multidrug resistance.

Slate DL, Bruno NA, Casey SM, Zutshi N, Garvin LJ, Wu H, Pfister JR.

Anticancer Res. 1995 May-Jun;15(3):811-4.

PMID:
7645963
10.

Improving estimates of HIV-1 seroprevalence among childbearing women: use of smaller blood spots.

Hoxie NJ, Vergeront JM, Pfister JR, Hoffman GL, Markwardt-Elmer PA, Davis JP.

Am J Public Health. 1992 Oct;82(10):1370-3.

11.

The action of (+/-)L-660,863 [(+/-)3-(3-amino-1,2,4-oxadiazole-5-yl)-quinuclidine] at muscarinic receptor subtypes in vitro.

Eglen RM, Harris GC, Ford AP, Wong EH, Pfister JR, Whiting RL.

Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):375-81.

PMID:
1620240
12.

Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea.

Eglen RM, Harris GC, Taylor M, Pfister JR, Whiting RL.

Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):29-35.

PMID:
1775190
13.

HIV-1 among childbearing women and newborns in Wisconsin.

Hoxie NJ, Vergeront JM, Pfister JR, Hoffman G, Markwardt PA, Davis JP.

Wis Med J. 1990 Nov;89(11):627-31.

PMID:
2136199
14.

HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin.

Hoxie NJ, Vergeront JM, Frisby HR, Pfister JR, Golubjatnikov R, Davis JP.

Am J Public Health. 1990 Sep;80(9):1129-31.

15.

RS 30026: a potent and effective calcium channel agonist.

Patmore L, Duncan GP, Clarke B, Anderson AJ, Greenhouse R, Pfister JR.

Br J Pharmacol. 1990 Apr;99(4):687-94.

16.

Isolation and Bioactivity of 2-Aminoquinoline from Leucopaxillus albissimus.

Pfister JR.

J Nat Prod. 1988 Sep;51(5):969-70. doi: 10.1021/np50059a027. No abstract available.

PMID:
21401193
17.
19.

Synthesis of three potential inhibitors of leukotriene biosynthesis.

Pfister JR, Murthy DV.

J Med Chem. 1983 Aug;26(8):1099-103.

PMID:
6308255
20.

Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.

Pfister JR, Wymann WE, Mahoney JM, Waterbury LD.

J Med Chem. 1980 Nov;23(11):1264-7.

PMID:
6779009
21.

Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.

Pfister JR, Wymann WE, Schuler ME, Roszkowski AP.

J Med Chem. 1980 Mar;23(3):335-8.

PMID:
6102608
22.

Dibenzotropone- and dibenzosuberonecarboxylic acids with bronchodilator activity.

Dunn JP, Green DM, Harrison IT, Nelson PH, Pfister JR, Roszkowski AP, Untch KG.

J Med Chem. 1979 Nov;22(11):1357-63.

PMID:
533884
23.

Synthesis and antiallergic activity of some mono- and disubstituted xanthone-2-carboxylic acids.

Pfister JR, Ferraresi RW, Harrison IT, Rooks WH, Fried JH.

J Med Chem. 1978 Jul;21(7):669-72.

PMID:
671465
24.

Xanthone-2-carboxylic acids, a new series of antiallergic substances.

Pfister JR, Ferraresi RW, Harrison IT, Rooks WH, Roszkowski AP, Van Horn A, Fried JH.

J Med Chem. 1972 Oct;15(10):1032-5. No abstract available.

PMID:
5069771

Supplemental Content

Loading ...
Support Center